Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder

By Seo Rubo J.   MacPherson Holly   Young Allan H.  

Pharmaceuticals, Vol. 3, Iss. 12, 2010-12 ,pp. : 3522-3542

MDPI

Access to resources Recommend Favorite

Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options

By Isidro Maria Luisa   Cordido Fernando  

Pharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 125-145

MDPI

Access to resources Recommend Favorite

Detection of Mycosphaerella graminicola in Wheat Leaves by a Microsatellite Dinucleotide Specific-Primer

By Abd-Elsalam Kamel   Bahkali Ali H.   Moslem Mohamed   De Wit Pierre J. G. M.   Verreet Joseph-Alexander  

International Journal of Molecular Sciences, Vol. 12, Iss. 1, 2011-01 ,pp. : 682-693

MDPI

Access to resources Recommend Favorite

Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines

By Perna Giampaolo   Alessandra Alciati   Raffaele Balletta   Elisa Mingotto   Giuseppina Diaferia   Paolo Cavedini   Maria Nobile   Daniela Caldirola  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 551-551

MDPI

Access to resources Recommend Favorite

A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy

By Huber Matthias   Lezius Susanne   Reibis Rona   Treszl Andras   Kujawinska Dorota   Jakob Stefanie   Wegscheider Karl   Völler Heinz   Kreutz Reinhold  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-07 ,pp. : 17456-17468

MDPI

Access to resources Recommend Favorite